ADPT earnings date and last-quarter result: last quarter beat, P/E -67.04. Updated 2026-07-23.
Adaptive Biotechnologies (ADPT) Research Hub
Adaptive Biotechnologies (ADPT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 26.27 USD (+2.98%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -67.04, market cap 3.52B. This hub links to the full technical, earnings and options research available for ADPT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 26.27 USD (+2.98%) |
| 52-week range | 16.43 USD – 30.74 USD |
| Trend regime | Range |
| 14-day RSI | 46.3 (Neutral) |
| Trailing P/E | -67.04 |
| Market cap | 3.52B |
| Dividend yield | 0.00% |
Available research for ADPT
Covered Call on ADPT: how it works, illustrative setup around the real 26.27 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ADPT: how it works, illustrative setup around the real 26.27 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ADPT: how it works, illustrative setup around the real 26.27 USD price, max profit/loss, breakeven and when to use it. Educational.
ADPT technical analysis: range, last 26.27 USD, RSI 46.3, 52w range 16.43 USD–30.74 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ADPT in?
Adaptive Biotechnologies (ADPT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ADPT in an uptrend or downtrend?
As of 2026-10-26, ADPT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ADPT's trailing P/E ratio?
ADPT's trailing P/E is -67.04, with a market cap of 3.52B. See the earnings research page for full valuation detail.